.,RadovanovicJ,BanjacK,ObradovicMIsenovicERAntioxidant enzymes and vascular diseases.2021;2(6):544555
use of therapies with potentially significant muscle effects (for example, androgens, insulin-like growth factor, growth hormone, systemic beta-agonists, neurotoxins or muscle relaxants or muscle-enhancing supplements) in any form within 3 months prior to screening
doi: 10.1016/j.gtc.2019.05.001
investigated luteolins anti-inflammatory and anti-fibrotic properties in A549 cells and a mouse model of bleomycin-induced PF
a limited reimbursement program launched October 7, 2025 capping enrollment at the first 2,500 qualified employees at roughly $299/month after reimbursement, leaving everyone past that cap on cash-pay
These associations involve chronic endogenous elevation, but they establish the biological plausibility of concern for long-acting exogenous analogues [8]